Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries

INTRODUCTION: Hemophilia A treatment involves replacing the deficient coagulation factor VIII. This process may involve multiple steps that might create a barrier to adherence. A new dual-chamber syringe (DCS; FuseNGo(®)) was recently introduced with the aim of simplifying reconstitution. AIM: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Cimino, Ernesto, Linari, Silvia, Malerba, Mara, Halimeh, Susan, Biondo, Francesca, Westfeld, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270299/
https://www.ncbi.nlm.nih.gov/pubmed/25525348
http://dx.doi.org/10.2147/PPA.S64709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270299/
https://www.ncbi.nlm.nih.gov/pubmed/25525348
http://dx.doi.org/10.2147/PPA.S64709

Ejemplares similares